No Data
Sichuan Hexie Shuangma (000935.SZ) subsidiary Hubei Jianxiang passed the on-site inspection of the USA FDA.
On December 8, Galunhui reported that sichuan hexie shuangma (000935.SZ) announced that recently, hubei jianxiang received an Establishment Inspection Report from the usa FDA. According to this inspection report, hubei jianxiang's quality and production system meet the standards of the usa FDA, and hubei jianxiang passed the onsite inspection by the usa FDA. The successful passing of the usa FDA onsite inspection signifies that the company's active pharmaceutical ingredient production base, hubei jianxiang, complies with the usa FDA requirements in terms of quality management system and production environment facilities.
Sichuan Shuangma: Report for the third quarter of 2024
Sichuan Hexie Shuangma (000935.SZ) released its performance for the first three quarters, with a net income of 0.245 billion yuan, a year-on-year decrease of 63.41%.
sichuan hexie shuangma (000935.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Sichuan Hexie Shuangma's cross-border acquisition of GLP-1 concept assets. Has the target company's finances been "optimized"? | Quick read announcement
①Last night, sichuan hexie shuangma announced plans to acquire GLP-1 concept Shenzhen Jianyuan at a total price of nearly 1.6 billion; ② Shenzhen Jianyuan's controlling shareholder, Star Silver Medicine, and Star Silver Group once provided funding to help Shenzhen Jianyuan "optimize" financial data.
Express News | Sichuan Hexie Shuangma Says It Plans to Buy 92.2% Stake in Shenzhen Jymed Technology for 1.6 Bln Yuan
sichuan hexie shuangma (000935.SZ): is planning a cash acquisition of equity.
Geelong on October 16th | Sichuan Hexie Shuangma (000935.SZ) announced a stock trade abnormal fluctuation notice, the company is currently planning a cash acquisition of equity, this transaction is still in the planning stage, with uncertainties, the specific transaction plan is subject to further demonstration and negotiation, the parties have not yet signed relevant agreements, the company will fulfill the disclosure obligations in a timely manner according to the progress of this transaction.
Sichuan Hexie Shuangma (SZSE:000935) May Have Issues Allocating Its Capital
